Nurse Practitioner · Deptford, NJ
NPI
1922426717
Since 2014
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1450 Almonesson Rd Ste 125
Deptford, NJ, 08096
Phone (856) 223-0965
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,508 services
Medicare patients, 2024
387
Average age 71
Drug cost, 2024
$3.5M
6,826 prescriptions
Company payments, 2025
$2,959
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy E Scanlon was code 99214 (office e&m - established), 533 times for 281 patients. In total Amy E Scanlon billed 1,508 services in 9 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 533 | 281 | $84.16 | $45K |
| 99213 Office E&M - Established | Office | 240 | 175 | $59.41 | $14K |
| 96372 Injection Administration | Office | 37 | 26 | $9.71 | $359 |
By year: 2022 $77K for 1,980 services; 2023 $107K for 4,691 services; 2024 $71K for 1,508 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy E Scanlon prescribed most often to Medicare patients was Levothyroxine Sodium, with 819 prescriptions and refills. In total Amy E Scanlon wrote 6,826 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 819 | 2,311 | 228 | $14K |
| Glimepiride Generic | 355 | 1,026 | 122 | $3,818 |
| Metformin Hcl Er Metformin Hcl | 328 | 907 | 104 | $3,798 |
| Ozempic Semaglutide | 323 | 601 | 84 | $555K |
| Atorvastatin Calcium Generic | 277 | 752 | 88 | $3,813 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 232 | 496 | 63 | $358K |
| Metformin Hcl Generic | 227 | 644 | 75 | $2,579 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 221 | 613 | 94 | $22K |
| Glipizide Er Glipizide | 201 | 548 | 49 | $2,764 |
| Tresiba Flextouch U-200 Insulin Degludec | 185 | 417 | 54 | $208K |
| Jardiance Empagliflozin | 171 | 425 | 55 | $242K |
| Farxiga Dapagliflozin Propanediol | 152 | 356 | 42 | $192K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 139 | 323 | 39 | $160K |
| Synthroid Levothyroxine Sodium | 137 | 404 | 41 | $12K |
| Rosuvastatin Calcium Generic | 127 | 367 | 40 | $2,258 |
Brand drugs: 3,199 claims; generic drugs: 3,014 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy E Scanlon $2,959 ($2,959 in general payments such as food, travel and fees) from 25 companies. The largest payer was Insulet Corporation with $473.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 42 | $473 |
| Mannkind Corporation MNKD | 14 | $321 |
| Ascendis Pharma Endocrinology Inc ASND | 15 | $319 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $246 |
| Novo Nordisk Inc NVO | 14 | $214 |
| Recordati_rare_diseases_inc. | 13 | $182 |
| Amgen Inc. AMGN | 11 | $181 |
| Amneal Pharmaceuticals LLC AMRX | 8 | $155 |
| Xeris Pharmaceuticals, Inc. | 5 | $94.04 |
| Lilly USA, LLC LLY | 5 | $91.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.